NEA Management Company’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

NEA Management Company’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,336	Closed	-$579K	–	59
2022 Q3	$579K	Hold	17,336	–	–	0.03%	55
2022 Q2	$693K	Hold	17,336	–	–	0.04%	55
2022 Q1	$912K	Hold	17,336	–	–	0.03%	56
2021 Q4	$960K	Hold	17,336	–	–	0.02%	55
2021 Q3	$1.34M	Hold	17,336	–	–	0.02%	61
2021 Q2	$2.25M	Hold	17,336	–	–	0.03%	59
2021 Q1	$28.5M	Hold	17,336	–	–	0.64%	33
2020 Q4	$4.06M	Hold	17,336	–	–	0.11%	53
2020 Q3	$1.79M	Hold	17,336	–	–	0.08%	48
2020 Q2	$680K	Hold	17,336	–	–	0.03%	45
2020 Q1	$589K	Hold	17,336	–	–	0.03%	48
2019 Q4	$811K	Hold	17,336	–	–	0.04%	44
2019 Q3	$1.55M	Hold	17,336	–	–	0.13%	40
2019 Q2	$2.36M	Hold	17,336	–	–	0.17%	38
2019 Q1	$4.75M	Hold	17,336	–	–	0.25%	37
2018 Q4	$2.18M	Hold	17,336	–	–	0.09%	40
2018 Q3	$7.11M	Hold	17,336	–	–	0.31%	38
2018 Q2	$9.36M	Hold	17,336	–	–	0.44%	30
2018 Q1	$7.97M	Buy	17,336 +3,540	+26%	+$1.93M	0.35%	34
2017 Q4	$9.24M	Hold	13,796	–	–	0.38%	31
2017 Q3	$8.69M	Hold	13,796	–	–	0.3%	30
2017 Q2	$6.62M	Hold	13,796	–	–	0.24%	30
2017 Q1	$10.3M	Hold	13,796	–	–	0.36%	24
2016 Q4	$13.5M	Buy	13,796 +4,348	+46%	+$4.97M	0.54%	20
2016 Q3	$12.6M	Hold	9,448	–	–	0.57%	20
2016 Q2	$8.28M	Hold	9,448	–	–	0.43%	24
2016 Q1	$13.2M	Hold	9,448	–	–	0.88%	19
2015 Q4	$17.5M	Hold	9,448	–	–	1.11%	17
2015 Q3	$18.5M	Hold	9,448	–	–	1.22%	16
2015 Q2	$21.4M	Hold	9,448	–	–	1.12%	15
2015 Q1	$26.5M	Buy	+9,448	New	+$24.8M	1.2%	17

Other funds holding TCON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

NEA Management Company's TCON Position: Q4 2022 in Review

NEA Management Company sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2022, closing a stake of 17,336 shares — an estimated $579K sold.

NEA Management Company first reported a position in TCON in Q1 2015 and held it in 31 quarters. The position peaked at $28.5M in Q1 2021. 31 funds tracked by Wall St. Rank hold TCON as of Q4 2022.

NEA Management Company reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
NEA Management Company sold 17,336 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $579K.
NEA Management Company first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 31 quarters.
NEA Management Company's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $28.5M in Q1 2021.
31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on NEA Management Company's 13F filing for Q4 2022, filed 10 Feb 2023.